Skip to main content
. 2018 Jul 4;11(3):65. doi: 10.3390/ph11030065

Figure 2.

Figure 2

Schematic depiction of the general molecular design of the target HBPLs consisting of a chelating agent (NODA-GA), a short PEG4-linker between radiometal complex and peptides, the symmetrical branching unit, the linkers of different length and rigidity (green) and the GRPR- and NPY(Y1)R-binding peptides BBN7–14 (cyan) and [Lys4,Trp5,Nle7]BVD15 (magenta).